The endothelium

Influencing vascular smooth muscle in many ways

Christopher Triggle, Samson Mathews Samuel, Shalini Ravishankar, Isra Marei, Gnanapragasam Arunachalam, Hong Ding

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

The endothelium, although only a single layer of cells lining the vascular and lymphatic systems, contributes in multiple ways to vascular homeostasis. Subsequent to the 1980 report by Robert Furchgott and John Zawadzki, there has been a phenomenal increase in our knowledge concerning the signalling molecules and pathways that regulate endothelial - vascular smooth muscle communication. It is now recognised that the endothelium is not only an important source of nitric oxide (NO), but also numerous other signalling molecules, including the putative endothelium-derived hyperpolarizing factor (EDHF), prostacyclin (PGI2), and hydrogen peroxide (H2O2), which have both vasodilator and vasoconstrictor properties. In addition, the endothelium, either via transferred chemical mediators, such as NO and PGI2, and (or) low-resistance electrical coupling through myoendothelial gap junctions, modulates flow-mediated vasodilatation as well as influencing mitogenic activity, platelet aggregation, and neutrophil adhesion. Disruption of endothelial function is an early indicator of the development of vascular disease, and thus an important area for further research and identification of potentially new therapeutic targets. This review focuses on the signalling pathways that regulate endothelial - vascular smooth muscle communication and the mechanisms that initiate endothelial dysfunction, particularly with respect to diabetic vascular disease.

Original languageEnglish
Pages (from-to)713-718
Number of pages6
JournalCanadian Journal of Physiology and Pharmacology
Volume90
Issue number6
DOIs
Publication statusPublished - 12 Dec 2012

Fingerprint

Vascular Smooth Muscle
Endothelium
Epoprostenol
Blood Vessels
Nitric Oxide
Diabetic Angiopathies
Lymphatic System
Gap Junctions
Vasoconstrictor Agents
Electric Impedance
Vasodilator Agents
Vascular Diseases
Platelet Aggregation
Vasodilation
Hydrogen Peroxide
Neutrophils
Homeostasis
Research
Therapeutics

Keywords

  • EDHF
  • Endothelium
  • Hyperglycaemia
  • Nitric oxide
  • PGI

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Pharmacology

Cite this

The endothelium : Influencing vascular smooth muscle in many ways. / Triggle, Christopher; Mathews Samuel, Samson; Ravishankar, Shalini; Marei, Isra; Arunachalam, Gnanapragasam; Ding, Hong.

In: Canadian Journal of Physiology and Pharmacology, Vol. 90, No. 6, 12.12.2012, p. 713-718.

Research output: Contribution to journalArticle

@article{c62b143a3b8a4724b851de57c8f38061,
title = "The endothelium: Influencing vascular smooth muscle in many ways",
abstract = "The endothelium, although only a single layer of cells lining the vascular and lymphatic systems, contributes in multiple ways to vascular homeostasis. Subsequent to the 1980 report by Robert Furchgott and John Zawadzki, there has been a phenomenal increase in our knowledge concerning the signalling molecules and pathways that regulate endothelial - vascular smooth muscle communication. It is now recognised that the endothelium is not only an important source of nitric oxide (NO), but also numerous other signalling molecules, including the putative endothelium-derived hyperpolarizing factor (EDHF), prostacyclin (PGI2), and hydrogen peroxide (H2O2), which have both vasodilator and vasoconstrictor properties. In addition, the endothelium, either via transferred chemical mediators, such as NO and PGI2, and (or) low-resistance electrical coupling through myoendothelial gap junctions, modulates flow-mediated vasodilatation as well as influencing mitogenic activity, platelet aggregation, and neutrophil adhesion. Disruption of endothelial function is an early indicator of the development of vascular disease, and thus an important area for further research and identification of potentially new therapeutic targets. This review focuses on the signalling pathways that regulate endothelial - vascular smooth muscle communication and the mechanisms that initiate endothelial dysfunction, particularly with respect to diabetic vascular disease.",
keywords = "EDHF, Endothelium, Hyperglycaemia, Nitric oxide, PGI",
author = "Christopher Triggle and {Mathews Samuel}, Samson and Shalini Ravishankar and Isra Marei and Gnanapragasam Arunachalam and Hong Ding",
year = "2012",
month = "12",
day = "12",
doi = "10.1139/Y2012-073",
language = "English",
volume = "90",
pages = "713--718",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "6",

}

TY - JOUR

T1 - The endothelium

T2 - Influencing vascular smooth muscle in many ways

AU - Triggle, Christopher

AU - Mathews Samuel, Samson

AU - Ravishankar, Shalini

AU - Marei, Isra

AU - Arunachalam, Gnanapragasam

AU - Ding, Hong

PY - 2012/12/12

Y1 - 2012/12/12

N2 - The endothelium, although only a single layer of cells lining the vascular and lymphatic systems, contributes in multiple ways to vascular homeostasis. Subsequent to the 1980 report by Robert Furchgott and John Zawadzki, there has been a phenomenal increase in our knowledge concerning the signalling molecules and pathways that regulate endothelial - vascular smooth muscle communication. It is now recognised that the endothelium is not only an important source of nitric oxide (NO), but also numerous other signalling molecules, including the putative endothelium-derived hyperpolarizing factor (EDHF), prostacyclin (PGI2), and hydrogen peroxide (H2O2), which have both vasodilator and vasoconstrictor properties. In addition, the endothelium, either via transferred chemical mediators, such as NO and PGI2, and (or) low-resistance electrical coupling through myoendothelial gap junctions, modulates flow-mediated vasodilatation as well as influencing mitogenic activity, platelet aggregation, and neutrophil adhesion. Disruption of endothelial function is an early indicator of the development of vascular disease, and thus an important area for further research and identification of potentially new therapeutic targets. This review focuses on the signalling pathways that regulate endothelial - vascular smooth muscle communication and the mechanisms that initiate endothelial dysfunction, particularly with respect to diabetic vascular disease.

AB - The endothelium, although only a single layer of cells lining the vascular and lymphatic systems, contributes in multiple ways to vascular homeostasis. Subsequent to the 1980 report by Robert Furchgott and John Zawadzki, there has been a phenomenal increase in our knowledge concerning the signalling molecules and pathways that regulate endothelial - vascular smooth muscle communication. It is now recognised that the endothelium is not only an important source of nitric oxide (NO), but also numerous other signalling molecules, including the putative endothelium-derived hyperpolarizing factor (EDHF), prostacyclin (PGI2), and hydrogen peroxide (H2O2), which have both vasodilator and vasoconstrictor properties. In addition, the endothelium, either via transferred chemical mediators, such as NO and PGI2, and (or) low-resistance electrical coupling through myoendothelial gap junctions, modulates flow-mediated vasodilatation as well as influencing mitogenic activity, platelet aggregation, and neutrophil adhesion. Disruption of endothelial function is an early indicator of the development of vascular disease, and thus an important area for further research and identification of potentially new therapeutic targets. This review focuses on the signalling pathways that regulate endothelial - vascular smooth muscle communication and the mechanisms that initiate endothelial dysfunction, particularly with respect to diabetic vascular disease.

KW - EDHF

KW - Endothelium

KW - Hyperglycaemia

KW - Nitric oxide

KW - PGI

UR - http://www.scopus.com/inward/record.url?scp=84868102387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868102387&partnerID=8YFLogxK

U2 - 10.1139/Y2012-073

DO - 10.1139/Y2012-073

M3 - Article

VL - 90

SP - 713

EP - 718

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 6

ER -